1-octadecanoyl-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine

Metabolite details

Identifier

DPRXQVIZBLENFV-NPQRSGSQSA-N

InChI Key

DPRXQVIZBLENFV-NPQRSGSQSA-N

IUPAC name

(21R)-27-amino-24-hydroxy-18,24-dioxo-19,23,25-trioxa-24λ⁵-phosphaheptacosan-21-yl (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate

Preferred name

1-octadecanoyl-2-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphoethanolamine

INN name

—

Synonym

GPEtn(18:0/22:5w6)

ChEBI

CHEBI:131665

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)

Observed in differential profiles

• Control_Plasma_vs_WY-14,643_Plasma
• Control_vs_AONFH_Stage_III_IV
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_12h_vs_Toxocara canis_12h
• G1_Ctrl_vs_G2_Ab